The bioactivation of nephrotoxic halogenated hydrocarbons involves initial hepatic glutathione S-conjugate formation and subsequent renal metabolism of the glutathione S-conjugates to the corresponding cysteine S-conjugates (1) . Nephrotoxic cysteine S-conjugates may form electrophilic episulfonium ions by nonenzymatic intramolecular rearrangements (2) or may be cleaved by renal cysteine conjugate 3-lyase (3-lyase) to produce pyruvate, ammonia, and unidentified sulfurcontaining reactive intermediates, which initiate renal proximal tubular cell death (3) (4) (5) . S-(1,2-Dichlorovinyl)-L-cysteine (DCVCys) is a model cysteine S-conjugate and a potent nephrotoxin (5-7), and a role for /3-lyase in DCVCys-induced nephrotoxicity has been established (5) .
The significant role of various bioactivation processes in chemical toxicology makes it important to identify classes of organic chemicals that may be converted to reactive intermediates. Therefore, in this study, the metabolism and nephrotoxicity of homocysteine analogues ( Fig. 1 ) of nephrotoxic cysteine S-conjugates were evaluated. Homocysteine S-conjugates, if cleaved by cystathionine ylyase (8) , should produce reactive intermediates similar to those produced by the action of /-lyase on the corresponding cysteine Sconjugates and are, therefore, expected to be nephrotoxic. MATERIALS AND METHODS Materials. L-Homoserine, DL-propargylglycine, pyridoxal phosphate, sodium 2-ketobutyrate, aminooxyacetic acid, probenecid, acetyl-coenzyme A, collagenase (type IV), and sodium pyruvate were purchased from Sigma. Deuterium oxide and deuterium chloride were obtained from Aldrich. Tetrabutylammonium phosphate was supplied by Eastman. Sodium 3-(trimethylsilyl)tetradeuteropropionate was obtained from Wilmad Glass (Buena, NJ). [1-14C]Acetyl-coenzyme A (58.7 mCi/mmol; 1 Ci = 37 GBq) was purchased from New England Nuclear.
Analyses. Melting points (uncorrected) were determined in open glass capillary tubes. Proton NMR spectra were recorded on a Bruker 270-MHz spectrometer. The elemental analyses (C, H, N, Cl, S) for S-(1,2-dichlorovinyl)-DL-amethylhomocysteine (DCVMeHcy, Fig. 1 Syntheses. DCVCys and S-(1,2-dichlorovinyl)-L-homocysteine (DCVHcy, Fig. 1 ) were synthesized by published procedures (5, 6) . S-(2-Benzothiazolyl)-L-homocysteine (BTHcy) was synthesized by the reaction ofthe disodium salt of L-homocysteine with 2-chlorobenzothiazole, as described for S-(2-benzothiazolyl)-L-cysteine (9); the details of the synthesis will be described elsewhere. S-Benzyl-DL-amethylhomocysteine was prepared from 4-(benzylthio)-2-butanone by the Bucherer-Bergs synthesis, and the resulting hydantoin was hydrolyzed with barium hydroxide (10) . The crude product S-benzyl-DL-a-methylhomocysteine [mp 217-220°C with decomposition, literature 252-254°C (10); NMR (2H20, 2HCl) 8 (5) . Protein concentrations were determined according to published methods (11, 12) . Renal cystathionine -lyase activity with L-homoserine (16 mM) as the substrate was determined by measuring the formation of 2-ketobutyric acid (13) . The production of 2-mercaptobenzothiazole from BTHC (0.3-0.8 mM) was measured as described for the metabolism of S-(2-benzothiazolyl)-L-cysteine (5, 9). Incubation mixtures contained 1 ml of potassium borate buffer (0.1 M, pH 8.6), 1.5-2 mg of rat kidney cytosolic protein in 0.4 ml of potassium chloride solution (1.15% wt/vol), and 0.1 ml of BTHCy solution in a final volume of 1.5 ml; in some experiments, the incubation mixture also contained 5 mM 2-ketobutyrate. Pyruvate formation from DCVCys (0.5-2 mM) was determined with kidney cytosol as previously described (9) . Rates of Nacetylation of DCVCys (0.25-2 mM) and DCVHcy (0.5-2 mM) were measured with [1-14C] acetyl-coenzyme A as described by Duffel and Jakoby (14) .
Metabolite Isolation and Characterization. For 2-mercaptobenzothiazole, the incubation mixture (final volume 1.5 ml) contained BTHcy (4 mM) and kidney cytosol (2 mg/ml) in potassium borate buffer (0.1 M, pH 8.6). The enzymatic reaction was terminated after 4 hr by addition of0.3 ml of 10%o (wt/vol) trichloroacetic acid. The acid-soluble supernatant was extracted with ethyl acetate (5 ml), the ethyl acetate extract was evaporated to dryness under a stream of nitrogen, and the residue was dissolved in methanol (2 ml) and analyzed by HPLC with an authentic sample of 2-mercaptobenzothiazole as a reference. For the characterization of 2-keto acids, the incubation mixture (final volume 7.5 ml) contained substrate (L-homoserine, DCVHcy, or BTHcy; 8 mM) and kidney cytosol (2 mg/ml) in potassium borate buffer (0.1 M, pH 8.6). Incubation flasks were shaken at 37°C, and samples (1.5 ml) were taken every hour. The enzymatic reaction was terminated by the addition of 0.3 ml of 10% trichloroacetic acid. A portion (0.5 ml) of the acid-soluble supernatant was mixed with 0.5 ml of 0.2% (wt/vol) 2,4-dinitrophenylhydrazine in 2 M HCl, diluted with methanol, and analyzed by HPLC as described by Hemming and Gubler (15) with authentic samples of 2-ketobutyrate and pyruvate as references. HPLC Analyses. A 4.6 x 250 mM Altex Spherisorb ODS 10-gm column with a 2-cm-long precolumn (Anspec, Ann Arbor, MI) packed with 37-to 53-pLm Pellicular ODS (Whatman) was used with an Altex 110A liquid chromatograph (Altex). For 2-mercaptobenzothiazole, the eluent was methanol/water (7:3, vol/vol), the flow rate was 1 ml/min, and the UV detection was at 321 nm. For 2-keto acids, the eluent was methanol/0.05 M tetrabutylammonium phosphate (6:4, vol/vol), the flow rate was 2 ml/min, and the UV detection was at 366 nm.
In Vitro Toxicity. Isolated kidney cells were prepared by the collagenase perfusion method of Jones et al. (16) . Cell viability and concentration were estimated in the presence of 0.2% trypan blue in a hemacytometer. Cell viability was also assessed by measurement of leakage of lactate dehydrogenase into the medium (17) . Cell viability by either method was typically 85-95%, and the yield was 30-50 x 106 cells per rat.
In Vivo Experiments. Male Fischer 344 rats were housed and fed as described previously (5 (Fig. 3) .
As was found in the in vivo studies, DCVHcy was a more potent toxin than was DCVCys; approximately equivalent losses of viability were produced with 0.1 mM DCVHcy and 1 mM DCVCys. Both aminooxyacetic acid and DL-propargylglycine protected against DCVHcy toxicity, and the a-methyl analogue DCVMeHcy was not toxic to the isolated cells ( 
DISCUSSION
In the present study, the homocysteine S-conjugate DCVHcy was a potent and selective nephrotoxin both in vivo and in isolated renal proximal tubular cells; indeed, DCVHcy is much more nephrotoxic than the corresponding cysteine S-conjugate DCVCys. The greater potency of DCVHcy compared to DCVCys in isolated renal proximal tubular cells demonstrates that the large difference in the in vivo nephrotoxicity of DCVHcy and DCVCys is not due to extrarenal factors but is due to differences in the intrarenal metabolism of the two compounds, differences in the target sites within the cell, or both. Experiments were carried out to examine the role of cystathionine y-lyase in the bioactivation and nephrotoxicity of DCVHcy. The catalytic mechanism of cystathionine y-lyase, a pyridoxal phosphate-dependent enzyme, involves Schiff base formation with the aamino group and subsequent abstraction of the proton at the a-carbon atom (18) . Hence DCVMeHcy, which lacks a proton on the a-carbon atom, cannot be cleaved by cystathionine y-lyase, and DCVMeHcy was not nephrotoxic. DL-Propargylglycine (19, 20) , and aminooxyacetic acid (21), a "suicide substrate" for and a known inhibitor of cystathionine y-lyase, both protected against DCVHcy-induced nephrotoxicity. Although these findings are compatible with a role for cystathionine y-lyase in DCVHcy-induced nephrotoxicity, the observation that no 2-ketobutyrate is formed from DCVHcy by renal cytosol does not support such a role; L-homoserine, a known substrate for cystathionine ylyase (13) , was metabolized to 2-ketobutyrate (Fig. 4,  pathway b ).
An alternative mechanism for the bioactivation of DCVHcy, which is consistent with the results obtained but does not require the participation of cystathionine y-tlyase, is shown in Fig. 4 . Transamination of DCVHcy, which is a known metabolic pathway for methionine, cysteine, and homocysteine (22) (23) (24) , should convert DCVHcy to the corresponding 2-keto acid. This intermediate is expected to be unstable due to the acidity of the protons on the p3-carbon atom and should readily undergo a nonenzymatic (3-elimination to yield a sulfur-containing reactive intermediate, S-(1,2-dichlorovinyl)thiol, and a Michael acceptor, 2-oxo-3-butenoic acid. This bioactivation scheme accounts for the observed lack of toxicity of DCVMeHcy, which cannot be deaminated by transamination. In addition, the formation of the Michael acceptor may contribute to the enhanced toxicity of DCVHcy; other Michael acceptors are toxic to renal epithelial cells (25) . Furthermore, DL-propargylglycine and aminooxyacetic acid inhibit a variety ofpyridoxal phosphatedependent enzymes (5, (19) (20) (21) 26) and block the toxicity of DCVHcy, which supports the involvement of pyridoxal phosphate-dependent enzymes in the bioactivation of DCVHcy.
Additional supportive evidence for this proposed bioactivation mechanism of DCVHcy is available. In the present study, the DCVHcy analogue BTHcy was metabolized by kidney cytosol to 2-mercaptobenzothiazole Probenecid inhibits the active accumulation of N-acetyl-Sbenzyl-L-cysteine by isolated renal cortical tubules and retards the plasma clearance ofN-acetyl-S-benzyl-L-cysteine (27, 28) and also blocks the nephrotoxicity of DCVCys and other nephrotoxic cysteine S-conjugates (2, 5) .
The bioactivation of DCVCys by l3-lyase and of DCVHcy by transamination requires a primary amino group; therefore, differences in rates of mercapturic acid formation from DCVCys and DCVHcy may explain, in part, the enhanced nephrotoxicity of DCVHcy. Although the Km values for the N-acetylation of DCVCys and DCVHcy by kidney microsomal N-acetyltransferase were similar, the rate of DCVCys N-acetylation was 4-fold greater than that of DCVHcy. Hence mercapturic acid formation is a much more important detoxication mechanism for cysteine S-conjugates than for homocysteine S-conjugates. Thus, intrarenal dispositional factors, such as N-acetylation, may contribute to the differences in nephrotoxicity between DCVHcy and DCVCys.
In summary, the present study describes a bioactivation mechanism for the homocysteine S-conjugate DCVHcy that involves an enzymatic deamination followed by a nonenzymatic l3-elimination to produce two reactive intermediates [S-(1,2-dichlorovinyl)thiol and 2-oxo-3-butenoic acid] that are apparently responsible for the cytotoxicity of DCVHcy (Fig. 4) . Other toxic and carcinogenic homocysteine conjugates have been reported (29) (30) (31) (32) and may undergo bioactivation by a mechanism similar to that shown in Fig. 4 . The remarkable nephrotoxic potency ofDCVHcy as compared to DCVCys may be attributable to intrarenal differences in bioactivation and detoxication. The role of alternative bioactivation and detoxication mechanisms for toxic and carcinogenic homocysteine S-conjugates warrants further investigation.
